Metraipolis › archive › dc_bd3ef328a51e

Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:41223192

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41223192
DOI
10.1371/journal.pone.0336721
License (as archived)
solo-consultazione
Archived
2026-11-08T15:47:31.297Z
SHA-256 of the archived text
5cb894f20bdae9c6d84c894927b0b7b227cfca1b118cf65ae466f805d58a6696
Stable URL of this page
https://metraipolis.com/documento/dc_bd3ef328a51e

How to cite

Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:41223192 — Europe PMC (en), https://europepmc.org/article/MED/41223192 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd3ef328a51e (Metraipolis archive dc_bd3ef328a51e, sha256 5cb894f20bdae9c6d84c894927b0b7b227cfca1b118cf65ae466f805d58a6696)
BibTeX
@misc{dcbd3ef328a51e,
  title = {Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database — Europe PMC PMID:41223192},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41223192},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd3ef328a51e; sha256 5cb894f20bdae9c6d84c894927b0b7b227cfca1b118cf65ae466f805d58a6696},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41223192. Agents can read the archived copy with the MCP tool read_document.